SHOULDER INNOVATIONS, INC. (SI) Quick Ratio
- Quick ratio · latest quarter: Value 8.56×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 8.56× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $109.87M ÷ $12.83M ≈ 8.56× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 109.87M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 12.83M USD | Liabilities, Current |
| Cash and equivalents | 24.46M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 74.53M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 10.87M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 22.92M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $109.87M | $12.83M | $24.46M | $74.53M | $10.87M | $22.92M | 8.56× |
| 2026-03-31 | $119.08M | $12.34M | $11.49M | $97.05M | $10.55M | $21.83M | 9.65× |
| 2025-12-31 | $132.57M | $14.20M | $26.87M | $97.43M | $8.27M | $21.59M | 9.34× |
| 2025-09-30 | $144.37M | $15.02M | $54.93M | $82.35M | $7.08M | $19.36M | 9.61× |
| 2025-06-30 | $46.52M | $12.49M | $27.05M | $12.58M | $6.89M | $17.08M | 3.72× |
| 2024-12-31 | $20.17M | $7.65M | $6.12M | $8.92M | $5.12M | $13.96M | 2.64× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |